ARTICLE | Clinical News
Plecanatide regulatory update
February 8, 2016 8:00 AM UTC
Synergy submitted an NDA to FDA for plecanatide to treat chronic idiopathic constipation (CIC). If approved, the company hopes to launch the guanylate cyclase C ( GCC; GUCY2C) agonist in 1Q17. ...